These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 27050283)

  • 1. Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients.
    Marini O; Spina C; Mimiola E; Cassaro A; Malerba G; Todeschini G; Perbellini O; Scupoli M; Carli G; Facchinelli D; Cassatella M; Scapini P; Tecchio C
    Oncotarget; 2016 May; 7(19):27676-88. PubMed ID: 27050283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of circulating myeloid-derived suppressor cell subsets: predicting poor clinical efficacy and prognosis through T cell suppression in non-Hodgkin's lymphoma.
    Pu LF; Li MM; Feng XJ; Zhang T; Hu LH; Zheng HM; Charwudzi A; Ding YY; Liu J; Liu ZL; Xiong SD
    J Leukoc Biol; 2024 May; 115(6):1094-1107. PubMed ID: 38369808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma.
    Solórzano JL; Menéndez V; Parra E; Solis L; Salazar R; García-Cosío M; Climent F; Fernández S; Díaz E; Francisco-Cruz A; Khoury J; Jiang M; Tamegnon A; Montalbán C; Melero I; Wistuba I; De Andrea C; F García J
    Oncoimmunology; 2024; 13(1):2388304. PubMed ID: 39135889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.
    Dubinski D; Wölfer J; Hasselblatt M; Schneider-Hohendorf T; Bogdahn U; Stummer W; Wiendl H; Grauer OM
    Neuro Oncol; 2016 Jun; 18(6):807-18. PubMed ID: 26578623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
    Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
    Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Expansion of Circulating Granulocytic Myeloid-derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis.
    Uhel F; Azzaoui I; Grégoire M; Pangault C; Dulong J; Tadié JM; Gacouin A; Camus C; Cynober L; Fest T; Le Tulzo Y; Roussel M; Tarte K
    Am J Respir Crit Care Med; 2017 Aug; 196(3):315-327. PubMed ID: 28146645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated circulating myeloid-derived suppressor cells associated with poor prognosis in B-cell non-Hodgkin's lymphoma patients.
    Wang Y; Wang J; Zhu F; Wang H; Yi L; Huang K; Zhai Z
    Immun Inflamm Dis; 2022 May; 10(5):e616. PubMed ID: 35478441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients.
    Amini RM; Enblad G; Hollander P; Laszlo S; Eriksson E; Ayoola Gustafsson K; Loskog A; Thörn I
    BMC Cancer; 2019 Apr; 19(1):316. PubMed ID: 30953461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function.
    Choi J; Suh B; Ahn YO; Kim TM; Lee JO; Lee SH; Heo DS
    Tumour Biol; 2012 Feb; 33(1):121-9. PubMed ID: 22081309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.
    Jordan KR; Kapoor P; Spongberg E; Tobin RP; Gao D; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2017 Apr; 66(4):503-513. PubMed ID: 28108766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells.
    Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M
    J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of pregnancy-associated granulocytic myeloid-derived suppressor cell expansion and arginase-1 production in preeclampsia.
    Wang Y; Liu Y; Shu C; Wan J; Shan Y; Zhi X; Sun L; Yi H; Yang YG; He J
    J Reprod Immunol; 2018 Jun; 127():48-54. PubMed ID: 29763854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice.
    Bian Z; Shi L; Venkataramani M; Abdelaal AM; Culpepper C; Kidder K; Liang H; Zen K; Liu Y
    Eur J Immunol; 2018 Mar; 48(3):532-542. PubMed ID: 29120053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual roles of CD11b
    Ni M; Cui J; Yang X; Ding Y; Zhao P; Hu T; Zhan Y; Kang Q; Hu X; Zhao J; Xu Y; Chen L; Liu M; Zhao M; Zhang F; Huang S; Li Y; Yang X; Zhang L; Zhang T; Deng B; Yang B; Lu D; Wang J
    Front Immunol; 2024; 15():1403272. PubMed ID: 39040102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10/STAT3 signalling.
    Wang M; Ping Y; Li Z; Li J; Zhang Z; Yue D; Chen X; Wang L; Huang L; Huang J; Yang L; Zhao X; Yang S; Li H; Shi J; Li J; Zhang Y
    J Viral Hepat; 2019 Feb; 26(2):246-257. PubMed ID: 30339295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.
    Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K
    Front Immunol; 2021; 12():676679. PubMed ID: 34149712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma.
    Perez C; Botta C; Zabaleta A; Puig N; Cedena MT; Goicoechea I; Alameda D; San José-Eneriz E; Merino J; Rodríguez-Otero P; Maia C; Alignani D; Maiso P; Manrique I; Lara-Astiaso D; Vilas-Zornoza A; Sarvide S; Riillo C; Rossi M; Rosiñol L; Oriol A; Blanchard MJ; Rios R; Sureda A; Martin J; Martinez R; Bargay J; de la Rubia J; Hernandez MT; Martinez-Lopez J; Orfao A; Agirre X; Prosper F; Mateos MV; Lahuerta JJ; Blade J; San-Miguel JF; Paiva B
    Blood; 2020 Jul; 136(2):199-209. PubMed ID: 32325491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.